These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 25429537)
1. [Antimicrobial properties of ceftaroline fosamil]. Seifert H Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S85-6. PubMed ID: 25429537 [No Abstract] [Full Text] [Related]
2. [Zinforo™ (ceftaroline fosamil)--A new beta-lactam-cephalosporin with MRSA activity]. Welte T Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S89-90. PubMed ID: 25429539 [No Abstract] [Full Text] [Related]
3. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan. Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342 [TBL] [Abstract][Full Text] [Related]
4. Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials. Shorr AF; Kollef M; Eckburg PB; Llorens L; Friedland HD Diagn Microbiol Infect Dis; 2013 Mar; 75(3):298-303. PubMed ID: 23357290 [TBL] [Abstract][Full Text] [Related]
5. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern. Mokuolu AO; Jiya N; Adesiyun OO Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907 [TBL] [Abstract][Full Text] [Related]
6. Clinical aspects of antimicrobial resistance. Virk A; Steckelberg JM Mayo Clin Proc; 2000 Feb; 75(2):200-14. PubMed ID: 10683663 [TBL] [Abstract][Full Text] [Related]
7. Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials. Taboada M; Melnick D; Iaconis JP; Sun F; Zhong NS; File TM; Llorens L; Friedland HD; Wilson D J Antimicrob Chemother; 2016 Apr; 71(4):862-70. PubMed ID: 26702925 [TBL] [Abstract][Full Text] [Related]
8. Blood culture Gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection. Hautala T; Syrjälä H; Lehtinen V; Kauma H; Kauppila J; Kujala P; Pietarinen I; Ylipalosaari P; Koskela M Int J Antimicrob Agents; 2005 Apr; 25(4):329-33. PubMed ID: 15784313 [TBL] [Abstract][Full Text] [Related]
13. Ceftaroline fosamil: drug profile and clinical data. Kanafani ZA Future Microbiol; 2011 Jan; 6(1):9-18. PubMed ID: 21162631 [TBL] [Abstract][Full Text] [Related]
14. Ceftaroline fosamil for community-acquired pneumonia--Authors' reply. Zhong NS; Sun T; Wilson D; Melnick D Lancet Infect Dis; 2015 Sep; 15(9):999-1000. PubMed ID: 26333322 [No Abstract] [Full Text] [Related]
15. Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy. DiMondi VP; Drew RH; Chen LF Expert Rev Anti Infect Ther; 2011 Aug; 9(8):567-72. PubMed ID: 21819323 [TBL] [Abstract][Full Text] [Related]
16. Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections. Lamb HM; Ormrod D; Scott LJ; Figgitt DP Drugs; 2002; 62(7):1041-89. PubMed ID: 11985490 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of lower respiratory tract infections in elderly]. Iakovlev SV Ter Arkh; 1997; 69(12):57-63. PubMed ID: 9503539 [No Abstract] [Full Text] [Related]